M. Sanagi

发表

Antifibrotic Effects of Pirfenidone in Rat Proximal Tubular Epithelial Cells

A. Tahara, Y. Tomura, K. Takakura, 2012, Renal failure.

clinically-used ARBs: drug-target interaction analyses

M. Orita, Tomohiko Yamaguchi, H. Masuzaki, 2014 .

Distinct Properties of Telmisartan on Agonistic Activities for Peroxisome Proliferator-Activated Receptor γ among Clinically Used Angiotensin II Receptor Blockers: Drug-Target Interaction Analyses

M. Orita, Tomohiko Yamaguchi, H. Masuzaki, 2014, The Journal of Pharmacology and Experimental Therapeutics.

The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.

A. Fujimori, K. Sudoh, M. Sasamata, 2004, European journal of pharmacology.

A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats.

A. Fujimori, K. Sudoh, M. Sasamata, 2005, Vascular pharmacology.

In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ETA receptor antagonist, on the lower urinary tract

A. Fujimori, K. Sudoh, M. Sasamata, 2008 .

YM598, an Orally Active ETA Receptor Antagonist, Ameliorates the Progression of Cardiopulmonary Changes and Both-side Heart Failure in Rats with Cor Pulmonale and Myocardial Infarction

A. Fujimori, K. Sudoh, I. Yamaguchi, 2004, Journal of cardiovascular pharmacology.

Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels

M. Okada, A. Fujimori, M. Okada, 2009, British journal of pharmacology.

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist.

A. Fujimori, K. Sudoh, H. Harada, 2003, European journal of pharmacology.

Effect of L-DOPA/Benserazide on Propagation of Pathological α-Synuclein

M. Hasegawa, S. Hisanaga, M. Terada, 2019, Front. Neurosci..

Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.

A. Fujimori, K. Hayashi, M. Tanahashi, 2003, Pharmacological research.

Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.

A. Fujimori, K. Sudoh, M. Orita, 2001, Bioorganic & medicinal chemistry.

Distinct Properties of Telmisartan on Agonistic Activities for Peroxisome Proliferator-Activated Receptor γ among Clinically Used Angiotensin II Receptor Blockers: Drug-Target Interaction Analyses

M. Orita, Tomohiko Yamaguchi, H. Masuzaki, 2014, The Journal of Pharmacology and Experimental Therapeutics.